Surprisingly, we found that in the postmortem brain of AD patients and AD model mice brain, the relatively low levels of Id2 expression along with a reduced αK40 acetylation, implying the diminution of Id2 is correlated with AD progression. The gene discussed is ID2; the disease is Alzheimer disease.